Diversified Healthcare Tr (DHC) Hedge Fund Ownership (Q1 2026)

Q: Is it too late to buy Diversified Healthcare Tr (DHC) following the 2026 Q2 hedge fund 13F filings?

As of today, DHC has moved +0.0% since the 2026 Q2 13F filing date (August 14, 2026), compared to +0.0% for the XLRE sector ETF — an outperformance of +0.0%. Since the quarter end (June 30, 2026), DHC gained -9.9% vs +2.8% for XLRE. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Diversified Healthcare Tr (DHC)

230 + Investors. Track Smart Money conviction in DHC. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — DHC

Based on 231 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 3 quarters in a row

last 6Q

For 3 consecutive quarters, more hedge funds added DHC than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

🏔️

At the ownership peak (100% of max)

100% of all-time peak

231 hedge funds hold DHC right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.

📶

Steady growth — +13% more funds vs a year ago

fund count last 6Q

+27 new funds entered over the past year (+13% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.

🟢

More buyers than sellers — 63% buying

139 buying83 selling

Last quarter: 139 funds were net buyers (47 opened a brand new position + 92 added to an existing one). Only 83 were sellers (53 trimmed + 30 sold completely). A clear majority buying is a strong confirmation signal.

📈

More new buyers each quarter (+14 vs last Q)

new funds entering per quarter

Funds opening a new DHC position: 18 → 27 → 33 → 47. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.

🔒

58% of holders stayed for 2+ years

■ 58% conviction (2yr+) ■ 22% medium ■ 20% new

133 out of 231 hedge funds have held DHC for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

💰

Value +29% but shares only +3% — price-driven

Value

+29%

+3%

Last quarter: the total dollar value of institutional holdings rose +29%, but actual share count only changed +3%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.

🚀

Acceleration phase — new buyers rushing in

32 → 18 → 27 → 33 → 47 new funds/Q

New funds entering each quarter: 18 → 27 → 33 → 47. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.

🏛️

Veteran-anchored — 65% veterans vs 25% newcomers

■ 65% veterans ■ 10% 1-2yr ■ 25% new

Entry-cohort mix of 236 holders: 154 (65%) are 2+ year veterans, 23 entered 1–2 years ago, and 59 (25%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.

✅

Strong quality — 38% AUM from major funds

38% from top-100 AUM funds

48 of 228 holders rank in the top 100 by AUM, accounting for 38% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

3.7

out of 10

Low Exit Risk

Exit risk score 3.7/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2026 Q1)	Prior (2025 Q4)	Change
Funds Holding	230	213	7.98%
13F Shares	198M	191M	3.42%
Total Value	$1.19B	$924M	29.11%
New Positions	46	33	+13
Increased Positions	88	74	+14
Closed Positions	29	18	+11
Reduced Positions	52	50	+2
Total Calls	4	6	-33.33%
Total Puts	4	6	-33.33%
PUT/CALL Ratio	1.0	1.0	Neutral

Metric

All 13F Filers (2026 Q1)

Prior (2025 Q4)

Change

Funds Holding

230

213

7.98%

13F Shares

198M

191M

3.42%

Total Value

$1.19B

$924M

29.11%

New Positions

+13

Increased Positions

+14

Closed Positions

+11

Reduced Positions

Total Calls

-33.33%

Total Puts

-33.33%

PUT/CALL Ratio

1.0

Neutral

Institutional Holders (2026 Q2)

230 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in DHC. Verified SEC 13F-HR filings.

QUARTER:

2026 Q2 filings are still coming in. Only funds that have filed so far are shown — top holders may not have reported yet. Full 13F data typically settles by ~50 days after quarter-end.

FILTER:All New Added To Reduced No Change | Overweight >5%

Top 25 DHC holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	Flat Footed LLC	16.71%	23,487,002	$218.4M
2	BlackBarn Capital Partners LP	3.20%	4,075,000	$37.9M
3	Lonestar Capital Management LLC	2.83%	1,050,000	$9.8M
4	Nierenberg Investment Management Company, LLC	2.11%	456,110	$4.2M
5	Carronade Capital Management, LP	0.99%	6,139,329	$57.1M
6	Park West Asset Management LLC	0.66%	1,035,047	$9.6M
7	VARCOV Co.	0.63%	177,555	$1.7M
8	LDR Capital Management LLC	0.56%	52,261	$486K
9	Informed Momentum Co LLC	0.53%	639,031	$5.9M
10	Hennessy Advisors Inc	0.36%	1,207,300	$11.2M
11	Pavaki Capital Management LLC	0.29%	85,000	$412K
12	RBF Capital, LLC	0.29%	750,000	$7.0M
13	Centersquare Investment Management LLC	0.23%	2,862,591	$26.6M
14	Smith Asset Management Co., LLC	0.16%	22,293	$207K
15	Militia Capital Management LLC	0.14%	214,139	$1.4M
16	CastleKnight Management LP	0.10%	782,442	$7.3M
17	Gould Capital, LLC	0.09%	17,436	$162K
18	Victory Financial Group, LLC	0.09%	88,142	$820K
19	State of Wyoming	0.08%	90,131	$838K
20	Nomura Holdings Inc	0.07%	6,277,985	$58.4M
21	Healthcare of Ontario Pension Plan Trust Fund	0.07%	5,000,000	$46.5M
22	Inceptionr LLC	0.06%	25,607	$238K
23	Abel Hall, LLC	0.05%	32,336	$301K
24	Hudson Bay Capital Management LP	0.05%	2,000,000	$18.6M
25	MUFG Securities EMEA plc	0.05%	500,000	$4.7M

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — Diversified Healthcare Tr (DHC)

What does the Smart Money Trend signal show for DHC?

Buying streak — 3 quarters in a row: For 3 consecutive quarters, more hedge funds added DHC than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for DHC?

More buyers than sellers — 63% buying: Last quarter: 139 funds were net buyers (47 opened a brand new position + 92 added to an existing one). Only 83 were sellers (53 trimmed + 30 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for DHC holders?

Strong quality — 38% AUM from major funds: 48 of 228 holders rank in the top 100 by AUM, accounting for 38% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held DHC?

58% of holders stayed for 2+ years: 133 out of 231 hedge funds have held DHC for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Diversified Healthcare Tr (DHC) following the 2026 Q2 hedge fund 13F filings?

As of today, DHC has moved +0.0% since the 2026 Q2 13F filing date (August 14, 2026), compared to +0.0% for the XLRE sector ETF — an outperformance of +0.0%. Since the quarter end (June 30, 2026), DHC has gained -9.9% vs +2.8% for XLRE. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

Diversified Healthcare Tr (DHC)

Smart Money Signals — DHC

Buying streak — 3 quarters in a row

At the ownership peak (100% of max)

Steady growth — +13% more funds vs a year ago

More buyers than sellers — 63% buying

More new buyers each quarter (+14 vs last Q)

58% of holders stayed for 2+ years

Value +29% but shares only +3% — price-driven

Acceleration phase — new buyers rushing in

Veteran-anchored — 65% veterans vs 25% newcomers

Strong quality — 38% AUM from major funds

Institutional Sentiment Summary — DHC

Hedge Fund Ownership: DHC

Market Analysis: DHC

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: DHC

Is It Too Late to Buy Diversified Healthcare Tr (DHC) Based on Hedge Fund 13F Filings?

Hedge Fund Positioning: DHC

Statistics: DHC

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q2)

Frequently Asked Questions — Diversified Healthcare Tr (DHC)

Welcome to 13Foresight!